MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Gastroenterology_Gastrointestinal (to include Liver, Pancreas & metabolic dysfunction-associated steatotic liver disease (MASLD), Gout, MASH (Metabolic dysfunction-associated steatohepatitis), formerly, NASH (Non-Alcoholic SteatoHepatitis)Non-Alcoholic SteatoHepatitis (NASH)
Liminal BioSciences Inc. (NASDAQ: LMNL)
Organization & Developments: Liminal BioSciences
Parents
Liminal BioSciences Inc. (NASDAQ: LMNL)
Children
2021: Liminal Biosciences: Sale Of Plasma Therapeutics Business Leaves Cupboard Looking Bare_seekingalpha.com
2022: Liminal BioSciences Inc. 2022 Q3 - Results - Earnings Call Presentation_ seekingalpha.com
Focused on inflammatory, fibrotic and metabolic conditions in patients with liver, respiratory or renal disease, with an emphasis on rare or orphan diseases.
Jumps
Finance & Acquisitions: Liminal BioSciences
Key People: Liminal BioSciences